Sophie Ohlsson

2.5k total citations
30 papers, 752 citations indexed

About

Sophie Ohlsson is a scholar working on Pulmonary and Respiratory Medicine, Immunology and Genetics. According to data from OpenAlex, Sophie Ohlsson has authored 30 papers receiving a total of 752 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 11 papers in Immunology and 10 papers in Genetics. Recurrent topics in Sophie Ohlsson's work include Vasculitis and related conditions (21 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (10 papers) and Cell Adhesion Molecules Research (8 papers). Sophie Ohlsson is often cited by papers focused on Vasculitis and related conditions (21 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (10 papers) and Cell Adhesion Molecules Research (8 papers). Sophie Ohlsson collaborates with scholars based in Sweden, United States and United Kingdom. Sophie Ohlsson's co-authors include Mårten Segelmark, Jörgen Wieslander, Omran Bakoush, Thomas Hellmark, Ole Torffvit, Jan Tencer, Åsa Pettersson, Daina Selga, Anisha Tanna and Veronika Satrapová and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Sophie Ohlsson

28 papers receiving 734 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sophie Ohlsson Sweden 14 427 282 227 210 138 30 752
Silke R. Brix United Kingdom 11 254 0.6× 332 1.2× 233 1.0× 113 0.5× 89 0.6× 21 676
Caroline Roozendaal Netherlands 17 303 0.7× 261 0.9× 73 0.3× 123 0.6× 96 0.7× 37 906
L H Noël France 11 256 0.6× 96 0.3× 311 1.4× 129 0.6× 71 0.5× 18 605
Bill Paspaliaris Australia 7 422 1.0× 145 0.5× 100 0.4× 90 0.4× 134 1.0× 10 588
W L Gross Germany 12 691 1.6× 170 0.6× 102 0.4× 116 0.6× 151 1.1× 27 841
T. Quéméneur France 13 408 1.0× 102 0.4× 106 0.5× 103 0.5× 154 1.1× 41 638
M-H Zhao China 15 170 0.4× 365 1.3× 296 1.3× 113 0.5× 51 0.4× 29 662
Joseph W. McCune United States 7 352 0.8× 91 0.3× 61 0.3× 82 0.4× 118 0.9× 11 554
Yannick van Sleen Netherlands 15 470 1.1× 192 0.7× 39 0.2× 69 0.3× 179 1.3× 41 644
Peter J. Eggenhuizen Australia 11 162 0.4× 255 0.9× 128 0.6× 160 0.8× 46 0.3× 31 548

Countries citing papers authored by Sophie Ohlsson

Since Specialization
Citations

This map shows the geographic impact of Sophie Ohlsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sophie Ohlsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sophie Ohlsson more than expected).

Fields of papers citing papers by Sophie Ohlsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sophie Ohlsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sophie Ohlsson. The network helps show where Sophie Ohlsson may publish in the future.

Co-authorship network of co-authors of Sophie Ohlsson

This figure shows the co-authorship network connecting the top 25 collaborators of Sophie Ohlsson. A scholar is included among the top collaborators of Sophie Ohlsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sophie Ohlsson. Sophie Ohlsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Frodlund, Martina, Katerina Chatzidionysiou, Anna Södergren, et al.. (2024). The serological immunogenicity of the third and fourth doses of COVID-19 vaccine in patients with inflammatory rheumatic diseases on different biologic or targeted DMARDs: a Swedish nationwide study (COVID-19-REUMA). Microbiology Spectrum. 12(4). e0298123–e0298123. 3 indexed citations
2.
Lundtoft, Christian, Ann Knight, Jennifer R. S. Meadows, et al.. (2024). The HLA region in ANCA-associated vasculitis: characterisation of genetic associations in a Scandinavian patient population. RMD Open. 10(2). e004039–e004039. 2 indexed citations
3.
Ohlsson, Sophie, et al.. (2024). Disease Activity and Tendency to Relapse in ANCA‐Associated Vasculitis Are Reflected in Neutrophil and Intermediate Monocyte Frequencies. Journal of Immunology Research. 2024(1). 6648265–6648265. 2 indexed citations
4.
Pettersson, Åsa, et al.. (2020). Increased Frequencies of Switched Memory B Cells and Plasmablasts in Peripheral Blood from Patients with ANCA‐Associated Vasculitis. Journal of Immunology Research. 2020(1). 8209737–8209737. 13 indexed citations
6.
Ohlsson, Sophie, et al.. (2019). Short-term medical treatment of hypercalcaemia in primary hyperparathyroidism predicts symptomatic response after parathyroidectomy. British journal of surgery. 106(13). 1810–1818. 12 indexed citations
8.
Johansson, Åsa, et al.. (2018). Phenotypic Characterization of Circulating CD4+ T Cells in ANCA-Associated Vasculitis. Journal of Immunology Research. 2018. 1–12. 9 indexed citations
9.
McAdoo, Stephen P., Anisha Tanna, Zdenka Hrušková, et al.. (2017). Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients. Kidney International. 92(3). 693–702. 140 indexed citations
10.
Alberici, Federico, Rona Smith, Matthias Cassia, et al.. (2016). TO037CLINICAL PREDICTORS OF RESPONSE TO RITUXIMAB IN ANCA-ASSOCIATED VASCULITIS: A EUROPEAN COHORT. Nephrology Dialysis Transplantation. 31(suppl_1). i77–i77. 1 indexed citations
11.
Ohlsson, Sophie, Åsa Pettersson, Anders Bengtsson, et al.. (2016). Impaired phagocytosis and reactive oxygen species production in phagocytes is associated with systemic vasculitis. Arthritis Research & Therapy. 18(1). 92–92. 17 indexed citations
12.
Linge, Petrus, Birgitta Gullstrand, Christian Lood, et al.. (2014). Serum from patients with systemic vasculitis induces alternatively activated macrophage M2c polarization. Clinical Immunology. 152(1-2). 10–19. 45 indexed citations
13.
Ohlsson, Sophie, et al.. (2014). Urinary Concentration of Monocyte Chemoattractant Protein-1 in Idiopathic Glomerulonephritis: A Long-Term Follow-Up Study. PLoS ONE. 9(1). e87857–e87857. 17 indexed citations
14.
Ohlsson, Sophie, Hans Herlitz, Sigrid Lundberg, et al.. (2013). Circulating Anti–Glomerular Basement Membrane Antibodies With Predominance of Subclass IgG4 and False-Negative Immunoassay Test Results in Anti–Glomerular Basement Membrane Disease. American Journal of Kidney Diseases. 63(2). 289–293. 70 indexed citations
15.
Ohlsson, Sophie, Jörgen Wieslander, & Mårten Segelmark. (2004). Circulating cytokine profile in anti‐neutrophilic cytoplasmatic autoantibody‐associated vasculitis: prediction of outcome?. Mediators of Inflammation. 13(4). 275–283. 56 indexed citations
16.
Hellmark, Thomas, et al.. (2003). Point Mutations of Single Amino Acids Abolish Ability of α3 NC1 Domain to Elicit Experimental Autoimmune Glomerulonephritis in Rats. Journal of Biological Chemistry. 278(47). 46516–46522. 7 indexed citations
17.
Ohlsson, Sophie, Ronald J. Falk, Yang Jia, et al.. (2003). Increased expression of the secretory leukocyte proteinase inhibitor in Wegener's granulomatosis. Clinical & Experimental Immunology. 131(1). 190–196. 6 indexed citations
18.
Ohlsson, Sophie, et al.. (2001). Novel distribution of the secretory leucocyte proteinase inhibitor in kidney. Mediators of Inflammation. 10(6). 347–350. 27 indexed citations
19.
Ohlsson, Sophie, et al.. (1997). Distribution of the Secretory Leucocyte Proteinase Inhibitor in Human Articular Cartilage. Biological Chemistry. 378(9). 1055–8. 13 indexed citations
20.
Eklöf, O., et al.. (1961). Benign non-epithelial tumours of the stomach and duodenum. A review of 27 cases.. PubMed. 121. 439–47. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026